Table 16 Immunization program for in vivo analysis.

From: In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine

Groups

First injection or priming (Day 0)

Second injection or first booster (Day 14)

Third injection or second booster (Day 28)

Challenge with C3 cells (Two weeks after second booster)

G1

pcDNA-L1

pcDNA-L1

pcDNA-L1

C3

G2

pcDNA-L2

pcDNA-L2

pcDNA-L2

C3

G3

pcDNA-L1 + pcDNA-L2

pcDNA-L1 + pcDNA-L2

pcDNA-L1 + pcDNA-L2

C3

G4 (Control)

pcDNA3.1 (empty vector)

pcDNA3.1 (empty vector)

pcDNA3.1 (empty vector)

C3

G5 (Control)

PBS

PBS

PBS

C3